Want to see HK:6872 full AI Analyst Report?
TenNor Therapeutics Suzhou Ltd. Class H (6872) Financial Statements
TenNor Therapeutics Suzhou Ltd. Class H Financial Overview
TenNor Therapeutics Suzhou Ltd. Class H's market cap is currently $3.67B. The company's EPS TTM is $0.00; its P/E ratio is -20.12; TenNor Therapeutics Suzhou Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -118.67M | $ -78.00M | $ -122.48M |
| EBITDA | $ -150.18M | $ -141.35M | $ -186.61M |
| Net Income | $ -153.24M | $ -145.93M | $ -191.84M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 183.76M | $ 97.82M | $ 58.11M |
| Total Assets | $ 227.04M | $ 132.89M | $ 96.05M |
| Total Debt | $ 28.65M | $ 53.02M | $ 59.42M |
| Net Debt | $ -155.11M | $ -44.79M | $ 1.31M |
| Total Liabilities | $ 73.18M | $ 1.03B | $ 854.96M |
| Stockholders' Equity | $ 153.86M | $ -898.05M | $ -758.91M |
| Cash Flow | |||
| Free Cash Flow | $ -87.65M | $ -48.80M | $ -98.63M |
| Operating Cash Flow | $ -87.19M | $ -48.60M | $ -98.12M |
| Investing Cash Flow | $ 2.50M | $ -185.00K | $ 70.38M |
| Financing Cash Flow | $ 170.63M | $ 88.50M | $ 4.73M |
Currency in CNY